Matthew is a Health Policy Analyst in our Life Sciences Health Industry Group. Drawing on nearly a decade of experience at Bloomberg Law – where he served as the Practice Lead for their Health Care Group – along with a background as a practicing lawyer and law clerk, Matt monitors federal and state policy developments coming out of CMS, OIG, HHS, FDA and other federal and state agencies.